APERAM S.A. NY SHS/1 O.N. Net Asset Quality Index
APERAM S.A. NY SHS/1 O.N. net asset quality index. APERAM S.A. NY SHS/1 O.N. (7AAN) has a Net Asset Quality Index of 48.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €6.78 Billion minus total liabilities of €3.49 Billion yields net assets of €3.29 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check APERAM S.A. NY SHS/1 O.N. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of APERAM S.A. NY SHS/1 O.N. (2022–2025)
Net asset quality index of APERAM S.A. NY SHS/1 O.N. from 2022 to 2025. This chart shows how APERAM S.A. NY SHS/1 O.N.'s Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the index stands at 48.5%, representing net assets of €3.29 Billion against total assets of €6.78 Billion EUR. See 7AAN book value for net asset value and shareholders' equity analysis.
APERAM S.A. NY SHS/1 O.N. Net Asset Quality Index by Year (2022–2025)
APERAM S.A. NY SHS/1 O.N. net asset quality index by year from 2022 to 2025. The table below presents the year-by-year Net Asset Quality Index for APERAM S.A. NY SHS/1 O.N. from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of APERAM S.A. NY SHS/1 O.N..
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.0% | €3.21 Billion | €5.17 Billion | €1.97 Billion | ▲ +4.4 pp |
| 2024 | 57.6% | €3.37 Billion | €5.84 Billion | €2.47 Billion | ▲ +2.1 pp |
| 2023 | 55.5% | €3.45 Billion | €6.21 Billion | €2.76 Billion | ▲ +1.3 pp |
| 2022 | 54.2% | €3.39 Billion | €6.26 Billion | €2.87 Billion | — |